MEMPHASYS LIMITED (MEM)

---

AI Coverage Rating: Low

ASX AI Signals has generated 0 signals for MEM during the last 90 days, indicating low trading activity

MEM Share Price
Current Price	$0.008
52 Week High	$0.008
52 Week Low:	$0.003
Trading at (% of 52 Week High)	100.00%

Business Overview

Memphasys Limited (ASX: MEM) is an Australian company that develops and commercializes advanced fertility technology aimed at improving outcomes for assisted reproductive treatments. Its primary product, Felix™, is designed to select the best sperm for use in in vitro fertilization (IVF), enhancing the chances of pregnancy for couples experiencing fertility issues.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

Latest  MEMPHASYS LIMITED(MEM)   News